Dr. Reddy's Laboratories Limited reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported sales was INR 70,830 million compared to INR 62,968 million a year ago. Net income was INR 13,070 million compared to INR 9,592 million a year ago. Basic earnings per share from continuing operations was INR 78.49 compared to INR 57.74 a year ago. Diluted earnings per share from continuing operations was INR 78.35 compared to INR 57.62 a year ago.
For the full year, sales was INR 279,164 million compared to INR 245,879 million a year ago. Net income was INR 55,684 million compared to INR 45,067 million a year ago. Basic earnings per share from continuing operations was INR 334.65 compared to INR 271.43 a year ago. Diluted earnings per share from continuing operations was INR 334.02 compared to INR 270.85 a year ago.